Effect of implanted insulin pumps on fluorescein transcapillary escape time in type 1 diabetes mellitus

To determine whether significant increases in fluorescein transcapillary escape time (FTET) would occur after treatment of patients with type 1 diabetes with insulin delivered intraperitoneally by a surgically implanted pump.

Nine patients with type 1 diabetes who were otherwise healthy and had received surgically implanted insulin pumps on a study protocol were recruited to have three measurements of FTET and glycosylated hemoglobin during an 18-month period. Serum fluorescein-albumin binding was measured at the time of the final test. Control FTETs were measured in 46 patients with type 1 diabetes who did not have insulin pumps and in 15 adults without diabetes.

In the implanted insulin pump group, 50% of the FTETs were below normal, but no significant longitudinal change in FTETs was noted in eight of the nine study patients. The mean FTETs in the implanted insulin pump group were significantly higher than those of the control patients with diabetes but without insulin pumps (mean, 88 versus 62 seconds; P<0.05) but significantly lower than those of the control subjects without diabetes (88 versus 163 seconds; P<0.001). Four of the nine patients with implanted insulin pumps had normal FTETs on all three studies. This subgroup had used insulin pumps (external + implanted) for significantly longer periods (6.2 versus 2.6 years; P<0.05) than the other five patients. These differences within the implanted pump group did not correlate with differences in glycosylated hemoglobin values or fluorescein-albumin binding; however, the glycosylated hemoglobin levels before insulin pump implantation were significantly lower than those of the other five patients. Three patients with onset of type 1 diabetes before age 10 years had the lowest FTETs.

Implanted insulin pumps did not alter FTETs between 6 months and 32 months after pump implantation. Total time on insulin pumps (external and implanted) is associated with normal FTET, and onset of diabetes before age 10 years is associated with abnormal FTET.